QualityStocksNewsBreaks Archives - Page 992 of 1561

MondayOct 12, 2020 11:58 am

QualityStocksNewsBreaks – Sugarmade Inc. (SGMD) Updates Shareholders on Two Key Initiatives

Sugarmade (OTCQB: SGMD), today issued a letter to its shareholders, on behalf of its CEO Jimmy Chan, that provided an update on coming expansion steps in regard to its BudCars delivery service as well as the company’s vertical integration. “Today, I want to highlight two themes that will help to drive our value proposition for shareholders over the intermediate term: geographic expansion for BudCars and our move to vertically integrate through the establishment of cultivation operations. Together, they represent tangible catalysts driving both top and bottom-line growth,” Chan stated in the update. “These are exciting times for Sugarmade. We have…

MondayOct 12, 2020 10:50 am

QualityStocksNewsBreaks – Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) Enters Definitive Agreements with New Cornerstone Shareholders

Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) today announced its entry into definitive agreements ("Definitive Agreements") with certain Barrick Gold Corporation subsidiaries and Augusta Investments Inc. in connection with the previously announced transaction pursuant to which Bullfrog will acquire rights to 1500 acres adjoining the company's Bullfrog Gold Deposit from Barrick, and Augusta and certain individuals identified by Augusta will concurrently complete a C$22 million investment in Bullfrog (the "Transaction"). "We are delighted to announce the signing of the Definitive Agreements and are encouraged by the positive market reaction to the announcement of the binding term sheet in…

MondayOct 12, 2020 9:48 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights New Glioblastoma-Focused Segment Airing on Lifetime TV

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today highlighted a new segment from The Balancing Act titled, "Behind the Mystery," which will air on Lifetime TV and focus on glioblastoma. The segment, live this morning, follows the unique story of a glioblastoma patient and clinical insights regarding the rare and difficult-to-treat disease from Dr. Sigmund Hsu, a member of CNS Pharmaceuticals’ Scientific Advisory Board. In addition, a re-airing of the segment is planned for October 23, 2020. "It is encouraging to…

FridayOct 09, 2020 2:58 pm

QualityStocksNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) Believes Quality is Key in Growing Sector

Pac Roots (CSE: PACR), a Canadian company dedicated to producing premium-quality strains and products, has taken steps for strategic positioning as the cannabis sector trends upward. The company’s first step in distinction begins with its focus and expertise in cultivating quality flower. A recent article discussing this reads, “Pac Roots is dedicated to delivering the finest cannabis genetics to its consumers, preserving the excellence of its carefully cultivated elite strains while also working to introduce superior new strains. While some companies may strive to be the largest cannabis grower, Pac Roots believes that the quality of the product is paramount.”…

FridayOct 09, 2020 2:32 pm

QualityStocksNewsBreaks – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) Creates Opportunity for US Investors to Tap Maricunga Gold Belt

GoldHaven Resources (CSE: GOH) (OTCQB: ATUMF), a Canada-based company engaged in the business of acquiring and exploring mineral resource properties, recently commenced trading on the OTCQB, a U.S. stock market operated by OTC Markets Group. The move creates opportunity for American investors to participate in the company’s activity with multiple high-priority targets in the prolific Maricunga Gold Belt of Chile. “We are very pleased to begin trading on OTCQB and continue our outreach into the U.S.,” stated GoldHaven president and CEO David Smith in a recent article discussing the news. “Further, it will provide liquidity in the trading of its…

FridayOct 09, 2020 2:04 pm

QualityStocksNewsBreaks – Net Element Inc. (NASDAQ: NETE) Looks to Compelling Opportunity Through Pending Reverse-Merger

Net Element (NASDAQ: NETE) previously entered a definitive agreement to merge with Mullen Technologies, a Southern California-based electric vehicle (“EV”) company, in a move intended to maximize shareholder value. The pending reverse-merger will allow privately-held Mullen stakeholders to acquire a majority of the new stock and accelerate the process of taking the company public, giving potential investors an opportunity to purchase relatively undervalued shares within the rapidly growing sector. Investors continue to divert capital into the EV industry, pushing EV stock prices to unprecedented levels. “We feel, after considering an array of strategic alternatives, that the agreement with Mullen provides…

FridayOct 09, 2020 12:10 pm

QualityStocksNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Featured in Simply Wall St Article

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company focused on the development of drug products for patients with high unmet medical need conditions or no alternative treatment options, was featured in a Simply Wall St article. The piece highlights PCSA Co-Founder Patrick Lin’s recent stock purchase at near current price. The article reads, “Potential Processa Pharmaceuticals Inc. (NASDAQ: PCSA) shareholders may wish to note that the Co-Founder, Patrick Lin, recently bought US$125k worth of stock, paying US$4.00 for each share. While that's a very decent purchase to our minds, it was proportionally a bit modest, boosting their holding by just…

FridayOct 09, 2020 11:07 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Begins Manufacturing of Lead Drug Candidate in Europe

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that its European manufacturer, BSP Pharmaceuticals S.p.A. ("BSP"), has begun the manufacturing process for Berubicin Drug Product, its lead drug candidate for the treatment of glioblastoma multiforme (“GBM”). GBM is an aggressive form of brain cancer currently considered incurable. “Our preparations for filing an IND for Berubicin require continued execution in both our clinical and manufacturing initiatives,” CNS Pharmaceuticals CEO John Climaco said in the news release. “With the manufacturing of our…

FridayOct 09, 2020 10:29 am

QualityStocksNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Provides Update on Portfolio Expansion in the US

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today provided an update on the progress of three of its portfolio companies in U.S. markets. The updates come only weeks before the U.S. election, where six states will vote on cannabis legalization initiatives and the potential power shift at the federal level could lead to more progressive policies for the industry. Among the highlights, Canopy Rivers announced the following: TerrAscend Corp. commenced sales from its newly expanded State Flower cultivation facility in San Francisco; High Beauty Inc. introduced canBE, a new line of natural, aloe-based products…

Site Search

Company Search

Category: QualityStocksNewsBreaks